Komodo Health

Komodo Health, founded in 2014 and headquartered in the United States, is an innovative company that aims to improve lives through its Healthcare Map™. The company's slogan "We’re helping our customers reach a higher evidentiary standard so that together, we can reduce the burden of disease" reflects its commitment to leveraging data-driven insights to make a positive impact on patient care and disease burden reduction.

The Komodo Health Platform differentiates itself by providing patient-level insights derived from a diverse range of data sources, including patients, practitioners, and health systems. This comprehensive approach allows the company to put patients at the center of clinical innovation, aligning with the current healthcare focus on delivering value and improving patient outcomes while reducing costs.

One of the notable aspects of Komodo Health's offering is its broad access to stakeholders across over fifty therapeutic areas, facilitated through its Healthcare Map™. This allows Life Sciences to extend the reach of innovative therapies, Patient Advocacy to make more targeted investments, Healthcare Practitioners to address unmet medical needs, and Payers to increase care quality while reducing costs.

The company recently secured a significant $200.00M Venture Round investment on 13 December 2022, with participation from prominent investors such as Coatue and Dragoneer Investment Group. This injection of capital is poised to support Komodo Health's efforts to further its mission of reducing the burden of disease and driving positive change in the healthcare industry.

For more information, interested parties can visit www.komodohealth.com to explore how they can collaborate in the pursuit of these vital goals.